In order to live better, you’ve got to breathe better. October is Healthy Lung Month, so let’s explore all the ways in which we can keep our lungs healthy and breathe easier. Key takeaways:  Lungs are an essential organ and the focal point of the respiratory...

Are you looking to learn more about drug pricing but don’t know where to start? Here’s a comprehensive guide that will provide clarity on this crucial issue. Drug prices in the United States are among the highest in the world, 3.44 times more expensive than the median price in other...

Chronic obstructive pulmonary disease (COPD) is among the top three leading causes of death globally. Learn the key symptoms of COPD and how best to manage the condition. Chronic obstructive pulmonary disease (COPD) is diagnosed in about 12.5 million people in the U.S. and is the third leading...

Prescription drug prices are rising more exorbitantly than the rate of inflation. Here are the culprits behind the rising costs of prescription medication. The price of prescription meds in the U.S. has risen dramatically over the past couple of years. This has little to do with inflation rates,...

Inflation directly affects the prices of prescription drugs in the U.S., but the Inflation Reduction Act can help combat the soaring prices and make them accessible to patients. According to a 2022 survey , one in three adults says they haven’t taken prescription medications due to the...

Prescription drug prices are on the rise, and patients will be forced to pay higher prices for the medications they need. Find out how you can navigate – and potentially avoid – cost inflation. Over the past several years, there has been a dramatic uptick in spending on prescription...

Among all developed nations, Americans pay the highest prices for prescription drugs. Here are the main reasons prescription drugs are so expensive in America. The cost of prescription medication in the U.S. has been on the rise for years. Between 2019 and 2020 , the price of most prescription...

Key Takeaways Most Americans support Medicare price reductions for prescription drugs Many Americans believe the government should be involved in setting price limits for prescription drugs Drug manufacturers and Big Pharma lobbyist groups have argued that lowering the prices of prescription...

An apple a day isn’t quite enough to keep the doctor away. Read our guide to what real preventative care requires. Key Takeaways: Prioritizing preventative steps delivers multiple benefits. Increased personal awareness, better budgeting, and easier condition management become...

The guidance on COVID-19 vaccinations and boosters in 2022 is always evolving. Here are the most current recommendations from the global health authorities. Key takeaways: Three manufacturers are approved to distribute vaccines. Age and current health details affect who is eligible. Some...

Generic medications are just as effective as their brand name counterparts, and they cost 80% to 85% less. Learn more about the differences. One of your first considerations when you’re buying a prescription is likely how much it’s going to cost. You can save money by going with a...

Medication therapy management is an empowering process for patients and care providers. Here’s how both sides can benefit. Effectively managing a chronic condition such as high blood pressure or COPD can be a burden on many levels. The responsibility is compounded when someone suffers from...

  Few prescriptions can be called cheap, but some drug expenses are stratospheric. Here are the nation’s most expensive drugs. Here’s a fact that’s hard to swallow: U.S. prescription drug prices are more than twice as expensive as those in other developed countries,...

Review the most up-to-date preventative measures to stay COVID-compliant from the classroom to the boardroom COVID-19 is still making its presence felt in America and around the world. The Centers for Disease Control and Prevention (CDC) is trying to keep pace by regularly updating their...

Learn more about how chronic diseases have significant direct and indirect costs for Americans of differing income levels and circumstances Chances are, most of us have experience – whether ourselves or someone we know – in dealing with a chronic ailment, such as heart disease, type...

Chronic diseases such as cancer, heart disease, and diabetes are among the leading causes of death in the U.S. Here are a few ways you can prevent them now. Avoiding chronic illness can help you lead a longer, healthier life. According to data from the Centers for Disease Control and Prevention...

Struggling with Prescription Costs? Here's How to Save in 2024 Each year, the price of medications continues to rise, with more than 600 drug prices increasing by an average of 5% to 6% back in 2022. As Americans still face financial challenges, partly due to the long-term effects of the COVID-19...

Many Americans are still struggling to cover health care costs as we begin 2022. Hundreds of drugs have already seen price hikes. Learn more about the state of prescription prices during the pandemic. As we begin 2022, many Americans wonder if the cost of their prescriptions will skyrocket in...

Every home needs a well-stocked medicine cabinet and this is especially true during the winter months when the common cold, flu and other winter ailments are particularly prevalent. While there is no cure for the common cold, there are many over-the-counter drugs to reduce those unpleasant cold...

Are you one of the many people in the United States planning to enjoy a smoke-free 2019? A new year comes with the promise of a clean slate and the opportunity to make resolutions to improve your quality of life, leaving you a healthier, stronger and happier person. A YouGov NY poll conducted last...

Do you have asthma and live near a busy road? If so, you may be one of those whose genetic profile means you are more susceptible to severe asthma symptoms exacerbated by traffic pollution… Around 26 million people in the US suffer from asthma, the equivalent to one in 13 Americans, but new...

The US Food and Drug Administration (FDA) has released the first of two new pieces of draft guidance that may eventually enable e-cigarette manufacturers to apply for regulated drug status for their products.  FDA Commissioner Scott Gottlieb, MD, said there is “no greater impact we can...

Americans suffering from severe emphysema now have a new treatment option available following the decision by the US Food and Drug Administration (FDA) to approve the Zephyr Endobronchial Valve, or Zephyr Valve. The device, marketed by Pulmonx Inc, is placed into diseased areas of the lungs by a...

GlaxoSmithKline’s once-daily triple therapy, the Trelegy Ellipta (fluticasone furoate, umeclidinium, vilanterol), is superior to dual combination therapies in reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD) with a history of exacerbations, new research...

Over the course of 2017, the number of approvals granted by the US Food and Drug Administration (FDA) reached a 21-year high. More than 1,000 generic drugs were approved by the agency, according to FDA Commissioner Scott Gottlieb, MD, while first-time generic drug approvals numbered 74. Novel drug...

The US Food and Drug Administration (FDA) has approved Sunovion’s Lonhala Magnair (glycopyrrolate), making it the first nebulized long-acting muscarinic antagonist (LAMA) treatment in the United States for patients with chronic obstructive pulmonary disease (COPD). It is expected to appear in...

Around 49 million American adults were still using tobacco products in 2015, according to new data published by the Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration’s (FDA) Center for Tobacco Products.  The Morbidity and Mortality Weekly Report...

The US Food and Drug Administration (FDA) has approved a new once-daily single inhaler triple therapy for treatment of certain adults with chronic obstructive pulmonary disease (COPD).  Trelegy Ellipta (furoate, umeclidinium, vilanterol) is indicated for patients on a fixed-dose combination...

Many patients with chronic obstructive pulmonary disease (COPD) who have Medicare Part D struggle to pay for medication and inhalers, it has been suggested. A report published in the Journal of the American Medical Association (JAMA) revealed one in nine Medicare beneficiaries have COPD. The...

GlaxoSmithKline (GSK) has issued a voluntary Class II recall for three batches of its Ventolin HFA 200D inhalers, totaling over 593,000 units. The recall only affects hospitals, pharmacies, wholesalers and retailers and will not require patients to return their medication. Ventolin inhalers are...